Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention

References

• Szulinska M , Gibas-Dorna M , Miller-Kasprzak E , et al. Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci . 2017;21:2473–2481.28617537
   PubMed Web of Science ®Google Scholar
• Samuel VT , Shulman GI . The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest . 2016;126:12–22. doi:10.1172/JCI77812 26727229
   PubMed Web of Science ®Google Scholar
• Rebiger L , Lenzen S , Mehmeti I . Susceptibility of brown adipocytes to pro-inflammatory cytokine toxicity and reactive oxygen species. Biosci Rep . 2016;36. doi:10.1042/BSR20150193
   Web of Science ®Google Scholar
• Wei Y , Chen K , Whaley-Connell AT , et al. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol . 2008;294:R673–R680. doi:10.1152/ajpregu.00561.2007 18094066
   PubMed Web of Science ®Google Scholar
• McGown C , Birerdinc A , Younossi ZM . Adipose tissue as an endocrine organ. Clin Liver Dis . 2014;18:41–58. doi:10.1016/j.cld.2013.09.012 24274864
   PubMed Web of Science ®Google Scholar
• Giralt M , Cereijo R , Villarroya F . Adipokines and the endocrine role of adipose tissues. Handb Exp Pharmacol . 2016;233:265–282.25903415
   PubMedGoogle Scholar
• Gong Z , Tas E , Yakar S , Muzumdar R . Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol . 2017;455:115–130. doi:10.1016/j.mce.2016.12.022 28017785
   PubMed Web of Science ®Google Scholar
• Lamers D , Famulla S , Wronkowitz N , et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes . 2011;60:1917–1925.21593202
   PubMed Web of Science ®Google Scholar
• Yanagimachi T , Fujita Y , Takeda Y , et al. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. Mol Metab . 2017;6:226–231. doi:10.1016/j.molmet.2016.12.009 28180064
   PubMed Web of Science ®Google Scholar
• Baumeier C , Schluter L , Saussenthaler S , et al. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol Metab . 2017;6:1254–1263. doi:10.1016/j.molmet.2017.07.016 29031724
   PubMed Web of Science ®Google Scholar
• Marques AP , Cunha-Santos J , Leal H , et al. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice. Biochim Biophys Acta Gen Subj . 2018;1862:403–413. doi:10.1016/j.bbagen.2017.11.012 29154902
   PubMed Web of Science ®Google Scholar
• Wunderlich CM , Hovelmeyer N , Wunderlich FT . Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT . 2013;2:e23878.24058813
   PubMedGoogle Scholar
• Rohrborn D , Eckel J , Sell H . Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Lett . 2014;588:3870–3877. doi:10.1016/j.febslet.2014.08.029 25217834
   PubMed Web of Science ®Google Scholar
• Sell H , Bluher M , Kloting N , et al. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care . 2013;36:4083–4090. doi:10.2337/dc13-0496 24130353
   PubMed Web of Science ®Google Scholar
• Svensson H , Oden B , Eden S , Lonn M . Adiponectin, chemerin, cytokines, and dipeptidyl peptidase 4 are released from human adipose tissue in a depot-dependent manner: an in vitro system including human serum albumin. BMC Endocr Disord . 2014;14:7. doi:10.1186/1472-6823-14-7 24447654
   PubMed Web of Science ®Google Scholar
• Cristancho AG , Lazar MA . Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol . 2011;12:722–734. doi:10.1038/nrm3198 21952300
   PubMed Web of Science ®Google Scholar
• Sarjeant K , Stephens JM . Adipogenesis. Cold Spring Harb Perspect Biol . 2012;4:a008417. doi:10.1101/cshperspect.a008417 22952395
   PubMed Web of Science ®Google Scholar
• Bauvois B , Djavaheri-Mergny M , Rouillard D , Dumont J , Wietzerbin J . Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene . 2000;19:265–272. doi:10.1038/sj.onc.1203292 10645005
   PubMed Web of Science ®Google Scholar
• Yuan Y , Xi Y , Chen J , et al. STAT3 stimulates adipogenic stem cell proliferation and cooperates with HMGA2 during the early stage of differentiation to promote adipogenesis. Biochem Biophys Res Commun . 2017;482:1360–1366. doi:10.1016/j.bbrc.2016.12.042 27940362
   PubMed Web of Science ®Google Scholar
• Cantwell MT , Farrar JS , Lownik JC , et al. STAT3 suppresses Wnt/beta-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine . 2018;111:434–444. doi:10.1016/j.cyto.2018.05.023 29934048
   PubMed Web of Science ®Google Scholar
• Liu Z , Gan L , Zhou Z , Jin W , Sun C . SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte. Immunobiology . 2015;220:947–953. doi:10.1016/j.imbio.2015.02.004 25720636
   PubMed Web of Science ®Google Scholar
• Mancini SJ , White AD , Bijland S , et al. Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation. Mol Cell Endocrinol . 2017;440:44–56. doi:10.1016/j.mce.2016.11.010 27840174
   PubMed Web of Science ®Google Scholar
• Kubota A , Takano H , Wang H , et al. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. J Mol Cell Cardiol . 2016;91:72–80. doi:10.1016/j.yjmcc.2015.12.026 26739213
   PubMed Web of Science ®Google Scholar
• Nagamine A , Hasegawa H , Hashimoto N , et al. The effects of DPP-4 inhibitor on hypoxia-induced apoptosis in human umbilical vein endothelial cells. J Pharmacol Sci . 2017;133:42–48. doi:10.1016/j.jphs.2016.12.003 28081947
   PubMed Web of Science ®Google Scholar
• Hwang HJ , Jung TW , Kim BH , et al. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochem Pharmacol . 2015;98:157–166. doi:10.1016/j.bcp.2015.08.098 26297911
   PubMed Web of Science ®Google Scholar
• Kornelius E , Lin CL , Chang HH , et al. DPP-4 inhibitor linagliptin attenuates abeta-induced cytotoxicity through activation of AMPK in neuronal cells. CNS Neurosci Ther . 2015;21:549–557. doi:10.1111/cns.12404 26010513
   PubMed Web of Science ®Google Scholar
• Ladenheim EE. Liraglutide and obesity: a review of the data so far. Drug Des Devel Ther . 2015;9:1867–1875. doi:10.2147/DDDT.S58459.
   Google Scholar
• Cao X , Zhou X , Liu XM , Zhou LH . Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats. J Mol Endocrinol . 2016;57:13–21. doi:10.1530/JME-16-0001 27151572
   PubMed Web of Science ®Google Scholar
• Shao Y , Yuan G , Zhang J , Guo X . Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression. Drug Des Devel Ther . 2015;9:1177–1184. doi:10.2147/DDDT.S79175
   Web of Science ®Google Scholar
• Ahmed RH , Huri HZ , Muniandy S , et al. Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance. Clin Biochem . 2017;50:746–749. doi:10.1016/j.clinbiochem.2017.03.008 28288852
   PubMed Web of Science ®Google Scholar
• Shin J , Fukuhara A , Onodera T , et al. Regulation of dipeptidyl peptidase-4, its substrate chemokines, and their receptors in adipose tissue of ob/ob mice. Horm Metab Res . 2017;49:380–387. doi:10.1055/s-0043-100115 28222464
   PubMed Web of Science ®Google Scholar
• Ghorpade DS , Ozcan L , Zheng Z , et al. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature . 2018;555:673–677. doi:10.1038/nature26138 29562231
   PubMed Web of Science ®Google Scholar
• Rohrborn D , Bruckner J , Sell H , Eckel J . Reduced DPP4 activity improves insulin signaling in primary human adipocytes. Biochem Biophys Res Commun . 2016;471:348–354. doi:10.1016/j.bbrc.2016.02.019 26872429
   PubMed Web of Science ®Google Scholar
• Varin EM , Mulvihill EE , Beaudry JL , et al. Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition. Cell Metab . 2019;29(320–334):e325. doi:10.1016/j.cmet.2018.10.001
   Web of Science ®Google Scholar
• Richard AJ , Stephens JM . The role of JAK-STAT signaling in adipose tissue function. Biochim Biophys Acta . 2014;1842:431–439. doi:10.1016/j.bbadis.2013.05.030 23735217
   PubMed Web of Science ®Google Scholar
• Kim KS , Kim SH . Effect of N-(D-Ribopyranosyl) taurine sodium salt on the differentiation of human preadipocytes and expression of adipokines through inhibition of STAT-3 signaling in differentiated human adipocytes. Adv Exp Med Biol . 2017;975:667–674.28849490
   PubMed Web of Science ®Google Scholar
• Minokoshi Y , Alquier T , Furukawa N , et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature . 2004;428(6982):569–574. doi:10.1038/nature02440 15058305
   PubMed Web of Science ®Google Scholar
• Yadav A , Kataria MA , Saini V , Yadav A . Role of leptin and adiponectin in insulin resistance. Clin Chim Acta . 2013;417:80–84. doi:10.1016/j.cca.2012.12.007 23266767
   PubMed Web of Science ®Google Scholar
• Beiroa D , Imbernon M , Gallego R , et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes . 2014;63(10):3346–3358. doi:10.2337/db14-0302 24917578
   PubMed Web of Science ®Google Scholar
• Zhou M , Mok MT , Sun H , et al. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. Oncogene . 2017;36:4135–4149. doi:10.1038/onc.2017.38 28319060
   PubMed Web of Science ®Google Scholar
• Zitman-Gal T , Einbinder Y , Ohana M , et al. The impact of liraglutide on the JAK-STAT pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells. J Diabetes . 2018.
   Web of Science ®Google Scholar